UnknownPhase 2NCT04899570
Zanubrutinib Combined With R-CHOP in Newly-diagnosed Intravascular Large B-cell Lymphoma
Studying Intravascular large B-cell lymphoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Peking Union Medical College Hospital
- Principal Investigator
- Daobin ZhouDepartment of Hematology, Peking University First Hospital
- Intervention
- Zanubrutinib(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2021 – 2025
Study locations (1)
- Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04899570 on ClinicalTrials.gov